Compounds > clopidogrel

clopidogrel and dihydropyridines

clopidogrel has been researched along with dihydropyridines in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Christ, G; Jilma, B; Lang, I; Siller-Matula, JM1
Jójártné, LO; Mártha, C; Szabóné, RP1
Kim, JY; Kim, YD; Lee, KY; Seo, KD; Yoon, YW1
Durstberger, M; Eichelberger, B; Gremmel, T; Koppensteiner, R; Panzer, S1

Trials

1 trial(s) available for clopidogrel and dihydropyridines

ArticleYear
Antiplatelet effect of clopidogrel can be reduced by calcium-channel blockers.
    Yonsei medical journal, 2014, Volume: 55, Issue:3

    Topics: Aged; Aged, 80 and over; Blood Platelets; Calcium Channel Blockers; Clopidogrel; Dihydropyridines; Drug Interactions; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine

2014

Other Studies

3 other study(ies) available for clopidogrel and dihydropyridines

ArticleYear
Calcium-channel blockers reduce the antiplatelet effect of clopidogrel.
    Journal of the American College of Cardiology, 2008, Nov-04, Volume: 52, Issue:19

    Topics: Aged; Angioplasty, Balloon, Coronary; Calcium Channel Blockers; Case-Control Studies; Cell Adhesion Molecules; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Dihydropyridines; Drug Interactions; Female; Flow Cytometry; Humans; Logistic Models; Male; Microfilament Proteins; Middle Aged; Phosphoproteins; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Reference Values; Risk Assessment; Sensitivity and Specificity; Statistics, Nonparametric; Ticlopidine; Treatment Outcome

2008
[Amorphous form in pharmaceutical technological research].
    Acta pharmaceutica Hungarica, 2011, Volume: 81, Issue:1

    Topics: Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Chlorhexidine; Clopidogrel; Dihydropyridines; Gemfibrozil; Glass; Ibuprofen; Loratadine; Meloxicam; Pharmaceutical Preparations; Piroxicam; Sorbitol; Technology, Pharmaceutical; Thiazines; Thiazoles; Ticlopidine

2011
Calcium-Channel Blockers Attenuate the Antiplatelet Effect of Clopidogrel.
    Cardiovascular therapeutics, 2015, Volume: 33, Issue:5

    Topics: Adenosine Diphosphate; Aged; Angioplasty; Aspirin; Calcium Channel Blockers; Clopidogrel; Dihydropyridines; Drug Interactions; Female; Flow Cytometry; Humans; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Ticlopidine

2015